Cancer's Shield Cracks: A New Mesothelioma Drug Shows Promise A recent clinical trial from the University of Vermont offers a promising example of creative thinking in cancer research.
By turning cancer's own defenses against it, researchers have developed an experimental mesothelioma drug that shows remarkable promise.
For years, oncologists have tried to outsmart cancer cells by flooding them with antioxidants, which neutralize toxic free radicals that damage healthy tissue.